Two Sigma Investments’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $179K | Sell |
89,451
-23,056
| -20% | -$46.1K | ﹤0.01% | 2890 |
|
2025
Q1 | $281K | Sell |
112,507
-24,827
| -18% | -$62.1K | ﹤0.01% | 2681 |
|
2024
Q4 | $405K | Buy |
137,334
+75,792
| +123% | +$224K | ﹤0.01% | 2567 |
|
2024
Q3 | $185K | Sell |
61,542
-5,969
| -9% | -$18K | ﹤0.01% | 2746 |
|
2024
Q2 | $235K | Sell |
67,511
-76,875
| -53% | -$268K | ﹤0.01% | 2604 |
|
2024
Q1 | $762K | Sell |
144,386
-47,673
| -25% | -$252K | ﹤0.01% | 2062 |
|
2023
Q4 | $987K | Buy |
+192,059
| New | +$987K | ﹤0.01% | 2014 |
|
2023
Q2 | – | Sell |
-11,043
| Closed | -$41.3K | – | 3199 |
|
2023
Q1 | $41.3K | Sell |
11,043
-10,990
| -50% | -$41.1K | ﹤0.01% | 2705 |
|
2022
Q4 | $68.1K | Sell |
22,033
-6,170
| -22% | -$19.1K | ﹤0.01% | 2499 |
|
2022
Q3 | $129K | Buy |
28,203
+26,425
| +1,486% | +$121K | ﹤0.01% | 2144 |
|
2022
Q2 | $47K | Sell |
1,778
-11,109
| -86% | -$294K | ﹤0.01% | 2285 |
|
2022
Q1 | $479K | Sell |
12,887
-2,837
| -18% | -$105K | ﹤0.01% | 2003 |
|
2021
Q4 | $920K | Sell |
15,724
-21,565
| -58% | -$1.26M | ﹤0.01% | 1694 |
|
2021
Q3 | $3.07M | Sell |
37,289
-2,348
| -6% | -$193K | 0.01% | 1141 |
|
2021
Q2 | $3.75M | Buy |
39,637
+8,372
| +27% | +$791K | 0.01% | 1038 |
|
2021
Q1 | $2M | Buy |
31,265
+26,548
| +563% | +$1.7M | 0.01% | 1270 |
|
2020
Q4 | $275K | Buy |
4,717
+4,080
| +641% | +$238K | ﹤0.01% | 1754 |
|
2020
Q3 | $13K | Buy |
+637
| New | +$13K | ﹤0.01% | 1817 |
|